Table 2.

The relationships between NLR and mortality in cancer participants.

Mortality	NLR			Lower NLR (n = 3138)	Higher NLR (n = 1836)
	HR	95% CI	P value	HR	HR	95% CI	P value
All-cause mortality
Unadjusted	1.21	1.15–1.25	< 0.001	Ref	2.02	1.73–2.36	< 0.001
Model 1	1.11	1.07–1.14	< 0.001	Ref	1.44	1.27–1.63	< 0.001
Model 2	1.10	1.07–1.13	< 0.001	Ref	1.38	1.22–1.55	< 0.001
Cardiovascular mortality
Unadjusted	1.23	1.16–1.31	< 0.001	Ref	2.72	2.11–3.52	< 0.001
Model 1	1.14	1.08–1.21	< 0.001	Ref	1.74	1.36–2.22	< 0.001
Model 2	1.12	1.06–1.18	< 0.001	Ref	1.63	1.27–2.09	< 0.001
Cancer-specific mortality
Unadjusted	1.15	1.09–1.21	< 0.001	Ref	1.92	1.54–2.41	< 0.001
Model 1	1.07	1.01–1.12	0.014	Ref	1.48	1.19–1.86	< 0.001
Model 2	1.06	1.01–1.12	0.023	Ref	1.45	1.17–1.79	< 0.001

Survey sample weights were taken into consideration in the Cox models accompanying the NHANES data. Model 1 was adjusted for gender, age, race, marital status, educational level, family income level, smoke history. Model 2 was additionally adjusted for the presence of comorbidities such as DM, CHD, HF, HBP, high cholesterol, stroke, chronic bronchitis and liver diseases.

HF heart failure, CHD coronary heart disease, HBP hypertension, DM Diabetes.